Search Results for: Global Cancer Vaccine Market to


April 29, 2019

CHECKPOINT INHIBITORS – Novel Targets & Global Markets April 29, 2019

Laurie L. Sullivan and Cheryl L. Barton, PhD, say as manufacturers expand the clinical utility and healthcare professionals become more familiar with their efficacy and safety profiles, the checkpoint inhibitor market will continue to expand, becoming the cornerstone of many cancer treatment regimens.

November 27, 2017

Immunovaccine & Leidos Expand Collaboration November 27, 2017

Immunovaccine Inc. recently announced it is expanding its collaboration with Leidos to develop preventative, peptide-based malaria vaccine candidates. The US...
January 13, 2017

EXECUTIVE INTERVIEW – Viral Gene: Protein-Targeting Cancer Vaccine Could Boost Survival Rates January 13, 2017

Harry A. Arena, MBA, President & CEO of TDT, Chris Kim, President & General Counsel, Viral Gene, Inc., and Dr. Scott Waldman, Professor & Chair of Sidney Kimmel Medical College’s Department of Pharmacology & Experimental Therapeutics at Thomas Jefferson University, discuss the unique characteristics of the vaccine, the patients who will benefit the most, and how a research team captured the attention of investors.

November 19, 2015

CELL CULTURE MARKET – 3D Cell Cultures: Next Generation & New Challenges November 19, 2015

Kevin James and Robert G. Hunter of BCC Research say significant growth within the biopharmaceuticals industry is spurring unprecedented innovation in and demand for cell culture products for the purposes of drug discovery and safety testing. While 2D cell cultures have been in laboratory use since the 1950s, the market for 3D cultures has witnessed spectacular growth throughout the past decade.